✦ LIBER ✦

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

✍ Scribed by Akira Sawaki; Kenji Yamao; Tsuneya Nakamura; Takashi Suzuki; Kenji Okubo; Kazuo Hara; Hiroki Kawai; Yoshitaka Yamamura; Seiji Ito; Yoshinari Mochiduki; Ryuzo Ohno

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 139 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-003-1298-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety profile of imatinib

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

✍ Toshirou Nishida; Kuniaki Shirao; Akira Sawaki; Masato Koseki; Takeshi Okamura; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 258 KB

Phase II study of motesanib in Japanese

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

✍ Akira Sawaki; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Toshihiko Doi; Mas 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 302 KB

Focal progression in patients with gastr

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients

✍ Salah-Eddin Al-Batran; Joerg Thomas Hartmann; Florian Heidel; Jan Stoehlmacher; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 326 KB

Correlation of immunophenotype with prog

Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate

✍ Lucian R. Chirieac; Jonathan C. Trent; Dejka M. Steinert; Haesun Choi; Ying Yang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

Effect of a tyrosine kinase inhibitor ST

Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor

✍ Akira Sawaki; Kazuhiko Ohashi; Kenji Yamao; Ken-ichi Inada; Yasuhiro Shimizu; Ak 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 564 KB

Expression of Bcl-2 in gastrointestinal

Expression of Bcl-2 in gastrointestinal stromal tumors : Correlation with progression-free survival in 81 patients treated with imatinib mesylate

✍ Dejka M. Steinert; Mauricio Oyarzo; Xuemei Wang; Haesun Choi; Peter F. Thall; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract ## BACKGROUND The natural history of gastrointestinal stromal tumor (GIST) has been revolutionized by imatinib mesylate (imatinib) therapy. Before imatinib, Bcl‐2 expression in GIST was associated with a worse prognosis or added no additional prognostic value. To the authors' knowledge